Skip to main content
impaact logo Return to homepage
  • Contact
    • Directory
  • About
    • Mission
    • Network Structure
      • Leadership
    • Areas of Research
      • Cure & Immunotherapy
      • Brain & Mental Health
      • Therapeutics
      • Tuberculosis
      • Social Behavioral Scientific Core (SBSC)
    • Early Career Investigator Program
    • Staff Spotlights
    • Funding Acknowledgements
    • Network Sites
      • Study Site Map
  • Studies
    • Research and Study Opportunities
    • Submit a Research Proposal
    • IMPAACT Study Snapshots
  • Community Engagement
    • ICAB Leadership Group
    • IMPAACT Community Advisory Board (ICAB)
    • Operations Center Staff
    • Resources
      • Acronyms
    • Site Community Advisory Boards
    • Community Meetings and Webinars
  • News & Events
    • Events and Conferences
    • IMPAACT Annual Meeting
    • Newsletters
    • Past Conference Presentations
    • Spotlight Series
  • Resources
    • COVID-19 Resources
    • HIV/AIDS Network Coordination (HANC)
    • Lab Center
      • Laboratory Committees
      • Laboratory Guidance Documents
      • Laboratory Resources for Quality Management
      • MiLab Resources
      • Specimen Repository
    • Manual of Procedures
    • Media Release Form
    • Network Logos & Templates
    • Regulatory Resources
    • Training Opportunities
    • NIH Updates
  • Publications
    • Abstracts
    • Manuscripts
  • Enter a search term.
Back to Directory

Debra Meres

Email

depayne@niaid.nih.gov

Phone

301-451-2775

Institution

Pharmaceutical Affairs Branch

Title

Research Pharmacist

Address

Pharmaceutical Affairs Branch
Henry M. Foundation for the Advancement of Military Medicine
6700-B Rockledge Drive, Suite 4222
Bethesda, MD 20817
United States of America
Request an Update

Affiliated Studies

P1032: Prevention of Development of Nevirapine-Resistance Mutations in Postpartum Women

DAIDS Number

10137

Research Area

Other

Study Status

Concluded

P1047: Safety And Immunogenicity Of QHPV In HIV+ Children 7-11 Years Of Age.

DAIDS Number

10163

Research Area

Other

Study Status

Concluded

P1056: GPO-VIR PK Study

DAIDS Number

10139

Research Area

Other

Study Status

Concluded

P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child

DAIDS Number

10270

Research Area

Other

Study Status

Concluded

P1069: GPO-VIR Z30

DAIDS Number

10620

Research Area

Other

Study Status

Concluded
Show All
IMPAACT logo Return to homepage

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.

Stay connected with the IMPAACT Network

Follow IMPAACT

Sign up for our newsletter

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Sitemap Privacy Notice

© 2020 IMPAACT Network